ImmunityBio
IBRX
IBRX
49 hedge funds and large institutions have $17.6M invested in ImmunityBio in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
19% less capital invested
Capital invested by funds: $21.8M → $17.6M (-$4.21M)
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
Holders
49
Holding in Top 10
–
Calls
$316K
Puts
$351K
Top Buyers
| 1 | +$916K | |
| 2 | +$655K | |
| 3 | +$232K | |
| 4 |
Morgan Stanley
New York
|
+$160K |
| 5 |
Renaissance Technologies
New York
|
+$159K |
Top Sellers
| 1 | -$363K | |
| 2 | -$274K | |
| 3 | -$267K | |
| 4 |
OGC
One68 Global Capital
New York
|
-$230K |
| 5 |
6CM
683 Capital Management
New York
|
-$223K |